physostigmine; eserine - PMC

Result Filters

You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 1 to 20 of 5420

<< First< Prev

Page of 271

Next >Last >>

Select item 65976731.

Adverse Effects of Physostigmine

Ann M. Arens, Tom Kearney

J Med Toxicol. 2019 Jul; 15(3): 184–191. Published online 2019 Feb 11. doi: 10.1007/s13181-019-00697-z

Correction in:: J Med Toxicol. 2019 Oct; 15(4): 310.

PMCID:: PMC6597673

Article PDF–430K

Select item 52675202.

The E Loop of the Transmitter Binding Site Is a Key Determinant of the Modulatory Effects of Physostigmine on Neuronal Nicotinic α4β2 Receptors

Xiaochun Jin, Megan M. McCollum, Allison L. Germann, Gustav Akk, Joe Henry Steinbach

Mol Pharmacol. 2017 Feb; 91(2): 100–109. Published online 2017 Feb. doi: 10.1124/mol.116.106484

PMCID:: PMC5267520

Article PDF–688K

Select item 50268573.

Physostigmine and Methylphenidate Induce Distinct Arousal States During Isoflurane General Anesthesia in Rats

Jonathan D. Kenny, Jessica J. Chemali, Joseph F. Cotten, Christa J. Van Dort, Seong-Eun Kim, Demba Ba, Norman E. Taylor, Emery N. Brown, Ken Solt

Anesth Analg. Author manuscript; available in PMC 2017 Nov 1.

Published in final edited form as: Anesth Analg. 2016 Nov; 123(5): 1210–1219. doi: 10.1213/ANE.0000000000001234

PMCID:: PMC5026857

Article PDF–1.7M

Select item 55483654.

Determination of the Residues in the Extracellular Domain of the Nicotinic α Subunit Required for the Actions of Physostigmine on Neuronal Nicotinic Receptors

Xiaochun Jin, Allison L. Germann, Daniel J. Shin, Gustav Akk, Joe Henry Steinbach

Mol Pharmacol. 2017 Sep; 92(3): 318–326. Published online 2017 Sep. doi: 10.1124/mol.117.108894

PMCID:: PMC5548365

Article PDF–1.1M

Select item 63605795.

In Vivo Effects of Neostigmine and Physostigmine on Neutrophil Functions and Evaluation of Acetylcholinesterase and Butyrylcholinesterase as Inflammatory Markers during Experimental Sepsis in Rats

Diane I. Bitzinger, Michael Gruber, Simon Tümmler, Manuela Malsy, Timo Seyfried, Florian Weber, Andreas Redel, Bernhard M. Graf, York A. Zausig

Mediators Inflamm. 2019; 2019: 8274903. Published online 2019 Jan 20. doi: 10.1155/2019/8274903

PMCID:: PMC6360579

Article PDF–2.9M

Select item 72944156.

Low acetylcholine during early sleep is important for motor memory consolidation

Samsoon Inayat, Qandeel, Mojtaba Nazariahangarkolaee, Surjeet Singh, Bruce L McNaughton, Ian Q Whishaw, Majid H Mohajerani

Sleep. 2020 Jun; 43(6): zsz297. Published online 2019 Dec 11. doi: 10.1093/sleep/zsz297

PMCID:: PMC7294415

Article PDF–11M

Select item 92834317.

Normalization of impaired emotion inhibition in bipolar disorder mediated by cholinergic neurotransmission in the cingulate cortex

Leila Nabulsi, Jennifer Farrell, Genevieve McPhilemy, Liam Kilmartin, Maria R. Dauvermann, Theophilus N. Akudjedu, Pablo Najt, Srinath Ambati, Fiona M. Martyn, James McLoughlin, Michael Gill, James Meaney, Derek Morris, Thomas Frodl, Colm McDonald, Brian Hallahan, Dara M. Cannon

Neuropsychopharmacology. 2022 Aug; 47(9): 1643–1651. Published online 2022 Jan 19. doi: 10.1038/s41386-022-01268-7

PMCID:: PMC9283431

Article PDF–1.8M

Select item 45378208.

Modeling bipolar disorder in mice by increasing acetylcholine or dopamine: Chronic lithium treats most, but not all features

Jordy van Enkhuizen, Morgane Milienne-Petiot, Mark A. Geyer, Jared W. Young

Psychopharmacology (Berl) Author manuscript; available in PMC 2016 Sep 1.

Published in final edited form as: Psychopharmacology (Berl). 2015 Sep; 232(18): 3455–3467. Published online 2015 Jul 5. doi: 10.1007/s00213-015-4000-4

PMCID:: PMC4537820

Article PDF–1.0M

Select item 44438589.

Ventral tegmental area cholinergic mechanisms mediate behavioral responses in the forced swim test

N.A. Addy, E.J. Nunes, R.J. Wickham

Behav Brain Res. Author manuscript; available in PMC 2016 Jul 15.

Published in final edited form as: Behav Brain Res. 2015 Jul 15; 288: 54–62. Published online 2015 Apr 9. doi: 10.1016/j.bbr.2015.04.002

PMCID:: PMC4443858

Article PDF–1.1M

Select item 253677010.

Activation and block of the adult muscle-type nicotinic receptor by physostigmine: single-channel studies

Julius Militante, Bei-Wen Ma, Gustav Akk, Joe Henry Steinbach

Mol Pharmacol. Author manuscript; available in PMC 2009 Sep 1.

Published in final edited form as: Mol Pharmacol. 2008 Sep; 74(3): 764–776. Published online 2008 Jun 3. doi: 10.1124/mol.108.047134

PMCID:: PMC2536770

Article PDF–3.0M

Select item 731367711.

Examining the role of muscarinic M5 receptors in VTA cholinergic modulation of depressive-like and anxiety-related behaviors in rats.

Eric J. Nunes, Laura E. Rupprecht, Daniel J. Foster, Craig W. Lindsley, P. Jeffrey Conn, Nii A. Addy

Neuropharmacology. Author manuscript; available in PMC 2021 Jul 1.

Published in final edited form as: Neuropharmacology. 2020 Jul; 171: 108089. Published online 2020 Apr 5. doi: 10.1016/j.neuropharm.2020.108089

PMCID:: PMC7313677

Article PDF–402K

Select item 354298512.

Physostigmine and Galanthamine Bind in the Presence of Agonist at the Canonical and Noncanonical Subunit Interfaces of a Nicotinic Acetylcholine Receptor

Ayman K. Hamouda, Tilia Kimm, Jonathan B. Cohen

J Neurosci. 2013 Jan 9; 33(2): 485–494. doi: 10.1523/JNEUROSCI.3483-12.2013

PMCID:: PMC3542985

Article PDF–2.7M

Select item 446971813.

The Use of Physostigmine by Toxicologists in Anticholinergic Toxicity

Joseph W. Watkins, Evan S. Schwarz, Anna M. Arroyo-Plasencia, Michael E. Mullins, on behalf of the Toxicology Investigators Consortium investigators

J Med Toxicol. 2015 Jun; 11(2): 179–184. Published online 2014 Dec 16. doi: 10.1007/s13181-014-0452-x

PMCID:: PMC4469718

Article PDF–298K

Select item 355045514.

Timing and Frequency of Physostigmine Redosing for Antimuscarinic Toxicity

Christopher Rosenbaum, Steven B. Bird

J Med Toxicol. 2010 Dec; 6(4): 386–392. Published online 2010 Apr 20. doi: 10.1007/s13181-010-0077-7

PMCID:: PMC3550455

Summary PDF–193K

Select item 304325815.

Treatment efficacy in a soman-poisoned guinea pig model: added value of physostigmine?

Marloes J. A. Joosen, August B. Smit, Herman P. M. van Helden

Arch Toxicol. 2011; 85(3): 227–237. Published online 2010 Sep 15. doi: 10.1007/s00204-010-0571-3

PMCID:: PMC3043258

Article PDF–568K

Select item 993826716.

Cholinergic system adaptations are associated with cognitive function in people recently abstinent from smoking: a (-)-[¹⁸F]flubatine PET study

Katina C. Calakos, Ansel T. Hillmer, Jon Mikael Anderson, Brittany LeVasseur, Stephen R. Baldassarri, Gustavo A. Angarita, David Matuskey, Michael Kapinos, Ming-Qiang Zheng, Yiyun Huang, Kelly P. Cosgrove

Neuropsychopharmacology. 2023 Mar; 48(4): 683–689. Published online 2023 Jan 21. doi: 10.1038/s41386-023-01535-1

PMCID:: PMC9938267

Article PDF–749K

Select item 568175817.

Adjunctive use of physostigmine salicylate (Anticholium®) in perioperative sepsis and septic shock: study protocol for a randomized, double-blind, placebo-controlled, monocentric trial (Anticholium® per Se)

Johannes B. Zimmermann, Nadine Pinder, Thomas Bruckner, Monika Lehmann, Johann Motsch, Thorsten Brenner, Torsten Hoppe-Tichy, Stefanie Swoboda, Markus A. Weigand, Stefan Hofer

Trials. 2017; 18: 530. Published online 2017 Nov 10. doi: 10.1186/s13063-017-2231-x